Skip to main content
. 2019 Nov 25;71(10):2645–2654. doi: 10.1093/cid/ciz1147

Table 1.

Baseline Characteristics of the Case Cohort

Characteristics Random Subcohorta n = 193 TB Death
Subcohort Control n = 180 TB Case n = 52 P-value Sub-cohort Control n = 180 Death Case n = 47 P-value
Age, median (IQR) 36 (31–43) 36 (31–43) 36 (31–43) .95 36 (31–43) 41 (33–48) .01
Female, no. (%) 96 (50%) 92 (51%) 24 (46%) .64 92 (51%) 21 (45%) .51
BMI < 18.5 kg/m2, no. (%) 55 (29%) 49 (27%) 18 (35%) .58 51 (28%) 15 (32%) .15
Karnofsky score
30–59 2 (1%) 2 (1%) 0 .70 1 (1%) 4 (9%) .001
60–89 67 (35%) 62 (35%) 21 (41%) 61 (34%) 23 (49%)
≥ 90 122 (64%) 114 (64%) 30 (59%) 116 (65%) 20 (43%)
WHO stage 3 or 4, no. (%) 67 (34%) 62 (34%) 18 (35%) > .95 61 (34%) 21 (45%) .18
Absence of poor prognostic factor, no. (%)a 130 (67%) 123 (68%) 33 (63%) .52 123 (68%) 27 (57%) .17
Absolute CD4+ T Cells, median (IQR) 22 (10–37) 22 (10–37) 24 (15–36) .48 22 (10–38) 15 (7–24) .01
log10 Human Immunodeficiency Virus -1 RNA, median (IQR) 5.36 (4.98–5.70) 5.36 (4.96–5.69) 5.44 (5.09–5.87) .22 5.35 (4.945–5.69) 5.43 (4.86–5.85) .41
Hemoglobin < 8 µg/dL, no. (%) 6 (3%) 6 (3%) 3 (6%) .42 5 (3%) 7 (15%) .004
Albumin, median (IQR) 4.8 (3.6–38) 4.7 (3.6–38.3) 27 (3.1–37) .29 4.8 (3.6–38.3) 4.1 (3.2–33.9) .02
Absolute neutrophil count, median (IQR) 1.67 (1.08–2.30) 1.61 (1.072.28) 2.15 (1.433.64) < .001 1.60 (1.07–2.27) 2.12 (1.463.94) < .001
Creatinine, median (IQR) 0.70 (0.60–0.86) 0.7 (0.60–0.84) 0.70 (0.60–0.80) .54 0.71 (0.60–0.87) 0.70 (0.58–1.0) .67
WBC (109 cells/L), median (IQR) 3.07 (2.40–3.97) 3.05 (2.35–3.90) 3.50 (2.70–4.70) .01 3.0 (2.4–3.9) 3.6 (2.9–5.2) .002
Monocyte:lymphocyte ratio, median (IQR) 0.43 (0.29–0.62) 0.43 (0.29–0.62) 0.49 (0.32–0.74) .14 0.43 (0.29–0.62) 0.42 (0.28–0.67) > .95
CD4 to CD8 ratio × 100, median (IQR) 4.44 (2.15–8.11) 4.32 (2.1–8.35) 5.01 (2.86–6.94) .31 4.42 (2.1–8.1) 3.52 (1.83–6.41) .15

Abbreviations: BMI, body mass index; IQR, interquartile range; N, number; TB, tuberculosis; WBC, white blood cell; WHO, World Health Organization.

aAbsence of poor prognostic factor defined as not having any of the following: hospitalization within past 30 days, BMI <18.5 or anemia <8 g/dl). Fischer exact p values were used to compare proportions and Wilcoxon rank sum tests to compare medians.